Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Provencher

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 16, 2001
The Southwestern Ontario Joint Replacement Pilot Project: electronic point-of-care data collection. Southwestern Ontario Study GroupR B Bourne, W J Sibbald, G Doig, et al.
The Journal of Pathology. Clinical Research|March 30, 2019
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinomaCécile Le Page, Martin Köbel, Liliane Meunier, et al.
Molecular Carcinogenesis|January 6, 2009
Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancerMichael C J Quinn, Abdelali Filali-Mouhim, Diane M Provencher, et al.
International Journal of Molecular Sciences|June 2, 2021
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma PrognosisLaudine Communal, Noemi Roy, Maxime Cahuzac, et al.
Molecular Carcinogenesis|April 16, 1999
Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascitesA P Manning, A M Mes-Masson, R J Seymour, et al.
BMC Medical Genomics|August 9, 2008
Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell linesNeal Al Cody, Magdalena Zietarska, Ali Filali-Mouhim, et al.
Scientific Reports|September 15, 2021
Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo modelsMelica Nourmoussavi Brodeur, Kayla Simeone, Kim Leclerc-Deslauniers, et al.
Human Pathology|November 20, 2016
Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancerMathieu P Pelletier, Vincent Q Trinh, Philippe Stephenson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancerCécile Le Page, Véronique Ouellet, Michael C J Quinn, et al.
Chemistry & Biology|July 28, 2010
Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresisTim J Wigle, Laurel M Provencher, Jacqueline L Norris, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 16, 2001
The Southwestern Ontario Joint Replacement Pilot Project: electronic point-of-care data collection. Southwestern Ontario Study GroupR B Bourne, W J Sibbald, G Doig, et al.
The Journal of Pathology. Clinical Research|March 30, 2019
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinomaCécile Le Page, Martin Köbel, Liliane Meunier, et al.
Molecular Carcinogenesis|January 6, 2009
Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancerMichael C J Quinn, Abdelali Filali-Mouhim, Diane M Provencher, et al.
International Journal of Molecular Sciences|June 2, 2021
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma PrognosisLaudine Communal, Noemi Roy, Maxime Cahuzac, et al.
Molecular Carcinogenesis|April 16, 1999
Expression of FHIT in primary cultures of human epithelial ovarian tumors and malignant ovarian ascitesA P Manning, A M Mes-Masson, R J Seymour, et al.
BMC Medical Genomics|August 9, 2008
Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell linesNeal Al Cody, Magdalena Zietarska, Ali Filali-Mouhim, et al.
Scientific Reports|September 15, 2021
Carboplatin response in preclinical models for ovarian cancer: comparison of 2D monolayers, spheroids, ex vivo tumors and in vivo modelsMelica Nourmoussavi Brodeur, Kayla Simeone, Kim Leclerc-Deslauniers, et al.
Human Pathology|November 20, 2016
Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancerMathieu P Pelletier, Vincent Q Trinh, Philippe Stephenson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancerCécile Le Page, Véronique Ouellet, Michael C J Quinn, et al.
Chemistry & Biology|July 28, 2010
Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresisTim J Wigle, Laurel M Provencher, Jacqueline L Norris, et al.
Pageof 11